Public-private partnership launched to develop new drugs for parasitic worm infections

Swiss TPH A new consortium of research institutes, universities, not-for-profit organizations, and pharmaceutical companies has teamed up to develop novel drugs for infections caused by parasitic worms (helminths), a debilitating group of diseases that includes river blindness, lymphatic filariasis, as well as infection with hookworm and whipworm, which together affect close to a billion people. (Photo: Danielle Powell/ Swiss TPH)

• www.swisstph.ch